financetom
Business
financetom
/
Business
/
MPLX Prices $4.5 Billion Debt Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MPLX Prices $4.5 Billion Debt Offering
Aug 8, 2025 3:15 AM

05:50 AM EDT, 08/08/2025 (MT Newswires) -- MPLX ( MPLX ) said late Thursday it priced a $4.5 billion public offering of unsecured senior notes.

The offering consists of $1.25 billion of 4.8% notes due 2031, $750 million of 5% notes due 2033, $1.5 billion of 5.4% notes due 2035, and $1 billion of 6.2% notes due 2055.

The company expects the offering to close Monday and plans to use part of the net proceeds to fund the pending acquisition of Northwind Delaware, among other things.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vale to produce up to 335 million tons of iron ore in 2025
Vale to produce up to 335 million tons of iron ore in 2025
Dec 3, 2024
SAO PAULO, Dec 3 (Reuters) - Brazilian miner Vale said on Tuesday it expects to produce between 325 million and 335 million metric tons of iron ore in 2025, following an output of about 328 million tons this year. Vale, one of the world's largest iron ore producers, released the estimates ahead of an investor day in New York, where...
Arrowhead Pharmaceuticals Files Request to Initiate Phase 1/2a Trial of Obesity Treatment
Arrowhead Pharmaceuticals Files Request to Initiate Phase 1/2a Trial of Obesity Treatment
Dec 3, 2024
08:28 AM EST, 12/03/2024 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Tuesday it had filed a request for regulatory clearance to initiate a phase 1/2a clinical trial of its experimental therapy, ARO-ALK7, to treat obesity. The company said the application was submitted to the New Zealand Medicines and Medical Devices Safety Authority for review. It added pending approval,...
BGC Group Sells Capitalab for $46 Million in Gross Proceeds
BGC Group Sells Capitalab for $46 Million in Gross Proceeds
Dec 3, 2024
08:19 AM EST, 12/03/2024 (MT Newswires) -- BGC Group ( BGC ) said Tuesday it sold Capitalab to technology firm Capitolis for gross proceeds of $46 million. The amount, which is subject to limited post-closing adjustments, represents a revenue multiple of about 7.5 times, BGC said. The financial services company said the one-time gain related to the sale will be...
Rakovina Therapeutics Increased Private Placement Offering to C$3 Million; Flags Upcoming Presentation
Rakovina Therapeutics Increased Private Placement Offering to C$3 Million; Flags Upcoming Presentation
Dec 3, 2024
08:25 AM EST, 12/03/2024 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) , a biopharmaceutical company, overnight Monday said it increased its previously announced private placement to C$3 million citing strong indications of interest from potential investors in the financing. In separate news, RKV today announced participation at the 13th Annual Tumour Models Summit. The company's president and chief scientific...
Copyright 2023-2026 - www.financetom.com All Rights Reserved